Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial
Wei X, Lin B, Huang Y, Yang S, Huang C, Shi L, Liu D, Zhang P, Lin J, Xu B, Guo D, Li C, He H, Liu S, Xue Y, Xu Y, Zhang H
JAMA network open · 107 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2023-03-17 · JAMA Netw Open · vol. 6 · número 3 · pág. e233513
- Editorial
- American Medical Association
- Citado
- 144 citas · más que el 100% de estudios similares · 19.7× el promedio de su campo
- Impacto
- Entre el 10 % más citado de su campo
- Referencias
- 47 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Dietary Effects on Health · Circadian rhythm and melatonin · Enhanced Recovery After Surgery
- Palabras clave
- Medicine, Nonalcoholic fatty liver disease, Internal medicine, Obesity, Waist, Body mass index, Fatty liver, Gastroenterology, Triglyceride, Randomized controlled trial, Disease, Cholesterol
- MeSH
- adipose tissue, humans, obesity, triglycerides, risk factors, adult, female, male, non-alcoholic fatty liver disease
17 autores
- Xueyun Wei🇨🇳Nanfang Hospital; Southern Medical University
- Bingquan Lin🇨🇳Nanfang Hospital; Southern Medical University
- Yan Huang🇨🇳Nanfang Hospital; Southern Medical University
- Shunyu Yang🇨🇳Nanfang Hospital; Southern Medical University
- Chensihan Huang🇨🇳Nanfang Hospital; Southern Medical University
- Linna Shi🇨🇳Nanfang Hospital; Southern Medical University
- Deying Liu🇨🇳Nanfang Hospital; Southern Medical University
- Peizhen Zhang🇨🇳Nanfang Hospital; Southern Medical University
- Jiayang Lin🇨🇳Nanfang Hospital; Southern Medical University
- Bingyan Xu🇨🇳Nanfang Hospital; Southern Medical University
- Dan Guo🇨🇳Nanfang Hospital; Southern Medical University
- Changwei Li🇺🇸Tulane University
- Hua He🇺🇸Tulane University
- Shiqun Liu🇨🇳Nanfang Hospital; Southern Medical University
- Yaoming Xue🇨🇳Nanfang Hospital; Southern Medical University
- Yikai Xu🇨🇳 · autor de correspondenciaNanfang Hospital; Southern Medical University
- Huijie Zhang🇨🇳 · autor de correspondenciaNanfang Hospital; Southern Medical University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Importance
The efficacy and safety of time-restricted eating (TRE) on nonalcoholic fatty liver disease (NAFLD) remain uncertain.
Objective
To compare the effects of TRE vs daily calorie restriction (DCR) on intrahepatic triglyceride (IHTG) content and metabolic risk factors among patients with obesity and NAFLD.
Design, setting, and participants
This 12-month randomized clinical trial including participants with obesity and NAFLD was conducted at the Nanfang Hospital in Guangzhou, China, between April 9, 2019, and August 28, 2021.
Interventions
Participants with obesity and NAFLD were randomly assigned to TRE (eating only between 8:00 am and 4:00 pm) or DCR (habitual meal timing). All participants were instructed to maintain a diet of 1500 to 1800 kcal/d for men and 1200 to 1500 kcal/d for women for 12 months.
Main outcomes and measures
The primary outcome was change in IHTG content measured by magnetic resonance imaging; secondary outcomes were changes in body weight, waist circumference, body fat, and metabolic risk factors. Intention-to-treat analysis was used.
Results
A total of 88 eligible patients with obesity and NAFLD (mean [SD] age, 32.0 [9.5] years; 49 men [56%]; and mean [SD] body mass index, 32.2 [3.3]) were randomly assigned to the TRE (n = 45) or DCR (n = 43) group. The IHTG content was reduced by 8.3% (95% CI, -10.0% to -6.6%) in the TRE group and 8.1% (95% CI, -9.8% to -6.4%) in the DCR group at the 6-month assessment. The IHTG content was reduced by 6.9% (95% CI, -8.8% to -5.1%) in the TRE group and 7.9% (95% CI, -9.7% to -6.2%) in the DCR group at the 12-month assessment. Changes in IHTG content were comparable between the 2 groups at 6 months (percentage point difference: -0.2; 95% CI, -2.7 to 2.2; P = .86) and 12 months (percentage point difference: 1.0; 95% CI, -1.6 to 3.5; P = .45). In addition, liver stiffness, body weight, and metabolic risk factors were significantly and comparably reduced in both groups.
Conclusions and relevance
Among adults with obesity and NAFLD, TRE did not produce additional benefits for reducing IHTG content, body fat, and metabolic risk factors compared with DCR. These findings support the importance of caloric intake restriction when adhering to a regimen of TRE for the management of NAFLD.
Trial registration
ClinicalTrials.gov Identifiers: NCT03786523 and NCT04988230.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.